Mitochondrial dysfunction in Parkinson's disease

Annals of Neurology

Volumn 44, Issue 3 SUPPL. 1, 1998, Pages

  Mizuno, Yoshikuni ^a   Yoshino, Hiroyo ^a   Ikebe, Shin Ichiro ^a   Hattori, Nobutaka ^a   Kobayashi, Tomonori ^a   Shimoda Matsubayashi, Satoe ^a   Matsumine, Hiroto ^a   Kondo, Tomoyoshi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL RECESSIVE DISORDER; BRAIN MITOCHONDRION; CHROMOSOME 6Q; CONFERENCE PAPER; ENZYME DEFICIENCY; GENE LOCUS; HUMAN; MITOCHONDRIAL RESPIRATION; NERVE CELL NECROSIS; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0031711713     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440715     Document Type: Conference Paper

References (107)

1. Boveris A. Mitochondrial production of superoxide radical and hydrogen peroxide. Adv Exp Biol Med 1977;10:161-169
2. Walker JE. The NADH:ubiquinone oxidoreductase of respiratory chains. Q Rev Biophys 1992;25:253-324
3. Walker JE, Arimendi JM, Dupuis A, et al. Sequences of 20 subunits of NADH:ubiquinone oxidoreductase from bovine heart mitochondria: application of a novel strategy for sequencing proteins using the polymerase chain reaction. J Mol Biol 1992;226:1051-1072
4. Nicklas WJ, Vyas I, Heikkila RE. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 1985;36:2503-2508
5. Ramsay RR, Salach JI, Dadgar J, Singer TP. Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism. Biochem Biophys Res Commun 1986;135:269-275
6. Mizuno Y, Saitoh T, Sone N. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion. Biochem Biophys Res Commun 1987; 143:294-299
7. Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989;1:1269
8. Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial Complex I deficiency in Parkinson's disease. J Neurochem 1990;54:823-827
9. Mizuno Y, Ohta S, Tanaka M, et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989;163:1450-1455
10. Hattori N, Tanaka M, Ozawa T, Mizuno Y. Immunohistochemical studies on complex I, II, III, and IV of mitochondria in Parkinson's disease. Ann Neurol 1991;30:563-571
11. Janetzky B, Hauck S, Youdim MBH, et al. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett 1994;169:126-128
12. Bindoff LA, Birch-Machin M, Cartlidge NEF, Parker WD Jr, Turnbull DM. Mitochondrial function in Parkinson's disease. Lancet 1989;2:49
13. Shoffner JM, Watts RL, Juncos JL, Torroni A, Wallace DC. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 1991;30:332-339
14. Nakagawa-Hattori Y, Yoshino H, Kondo T, Mizuno Y, Horai S. Is Parkinson's disease a mitochondrial disorder? J Neurol Sci 1992;107:29-33
15. Cardellach F, Martí MJ, Fernández-Solá J, et al. Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease. Neurology 1993;43:2258-2262
16. Blin O, Desnuelle C, Rascol O, et al. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci 1994;125: 95-101
17. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AH, Marsden CD. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 1992; 115:333-342
18. Anderson JJ, Ferrari R, Davis TL, Baronti F, Chase TN, Dagani F. No evidence for altered muscle mitochondrial function in Parkinson's disease. J Neurol Neurosurg Psychiatry 1993; 56:477-480
19. Didonato S, Zeviani M, Giovannini P, et al. Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients. Neurology 1993;43:2262-2268
20. Reichmann H, Janetzky B, Bischof F, et al. Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome. Eur Neurol 1994;34:263-267
21. Penn AMW, Roberts T, Hodder J, Allen PS, Shu G, Martin WRW. Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle. Neurology 1995;45:2097-2099
22. Parker WD Jr, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 1989;26:719-723
23. Yoshino H, Nakagawa-Hattori Y, Kondo T, Mizuno Y. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. J Neural Transm 1992;4: 27-34
24. Benecke R, Strümper P, Weiss H. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain 1993;116:1451-1463
25. Haas RH, Nasirian F, Nakano K, et al. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann Neurol 1995;37:714-722
26. Krige D, Carroll MT, Cooper JM, Marsden CD, Schapira AHV. Platelet mitochondrial function in Parkinson's disease. Ann Neurol 1992;32:782-788
27. Blake CT, Spitz E, Leehey M, Hoffer BJ, Boyson SJ. Platelet mitochondrial respiratory chain function in Parkinson's disease. Mov Disord 1997;12:3-8
28. Barroso N, Campos Y, Huertas R, et al. Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson's disease. Clin Chim Acta 1993;39:667-669
29. Martin MA, Molina JA, Jimenez-Jimenez FJ, et al. Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients. Neurology 1996;46:1343-1346
30. Singer TP, Ramsay RR, Ackrell BA. Deficiencies of NADH and succinate dehydrogenases in degenerative disease and myopathies. Biochim Biophys Acta 1995;1271:211-219
31. Mytilineou C, Werner P, Molinari S, Di-Rocco A, Cohen G, Yahr MD. Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease. J Neural Transm [PD Sect] 1994;8:223-228
32. Sheehan JP, Sweardlow RH, Parkier WD, Miller SW, Davis RE, Tuttle JB. Altered calcium homeostasis in cells transformed by mitochondrial from individuals with Parkinson's disease. J Neurochem 1997;68:1221-1233
33. Mizuno Y, Matuda S, Yoshino H, Mori H, Hattori N, Ikebe S. An immunohistochemical study on α-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann Neurol 1994; 35:204-210
34. Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 90:457-465
35. Ikebe S, Tanaka M, Ohno K, et al. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem Biophys Res Commun 1990;170:1044-1048
36. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace D. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genet 1992;2:324-329
37. Soong K, Hinton DR, Cortopassi G, Arnheim N. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nature Genet 1992;2:318-323
38. Simonetti S, Chen X, DiMauro S, Schon EA. Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR. Biochim Biophys Acta 1992;1180:113-122
39. Kapsa RM, Jean-Francois MJ, Lertrit P, et al. Mitochondrial DNA polymorphism in substantia nigra. J Neurol Sci 1996; 144:204-211
40. Ozawa T, Hayakawa M, Katsumata K, Yoneda M, Ikebe S, Mizuno Y. Fragile mitochondrial DNA: the missing link in the apoptotic neuronal cell death. Biochem Biophys Res Commun 1997;235:158-161
41. Hayakawa M, Hattori K, Sugiyama S, Ozawa T. Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts. Biochem Biophys Res Commun 1992; 189:979-985
42. Jenner P, Schapira AH, Marsden CD. New insights into the cause of Parkinson's disease. Neurology 1992;42:2241-2250
43. Ikebe S, Tanaka M, Ozawa T. Point mutations of mitochondrial genome in Parkinson's disease. Mol Brain Res 1995;28: 281-295
44. Richter C, Park J-W, Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 1988;85:6465-6467
45. Caron F, Jacq C, Rouviere-Yaniv J. Characterization of a hasten-like protein extracted from mitochondria. Proc Natl Acad Sci USA 1979;76:4265-4269
46. Clayton DA. Replication of animal mitochondrial DNA. Cell 1982;28:693-705
47. Gross NJ, Getz GS, Rubinowitz M. Apparent turnover of mitochondrial deoxyribonucleic acid and mitochondrial phospholipids in the tissue of rat. J Biol Chem 1969;244:1552-1562
48. Kunkel TA, Loeb LA. Fidelity of mammalian DNA polymerase. Science 1981;213:765-767
49. Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, Beal MF, Yang CC, Gearing M, Salvo R, Watts RL, Juncos JL, Hansen LA, Crain BJ, Fayad M, Reckord CL, Wallace DC. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 1993;17: 171-184
50. Mayr-Wohlfart U, Rodel G, Hennesberg A. Mitochondrial tRNA(Gln) and tRNA(Thr) gene variants in Parkinson's disease. Eur J Med Res 1997;2:111-113
51. Lücking CB, Kösel S, Mehraein P, Graeber MB. Absence of the mitochondrial A7237T mutation in Parkinson's disease. Biochem Biophys Res Commun 1995;211:700-704
52. Schnopp NM, Kösel S, Egensperger R, Graeber MB. Regional heterogeneity of mtDNA heteroplasmy in parkinsonian brain. Clin Neuropathol 1996;15:348-352
53. Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 1985;54:1015-1069
54. Chomyn A, Mariottini P, Cleeter MWJ, et al. Six unidentified reading frames of human mitochondrial DNA encode components of the respiratory-chain NADH dehydrogenase. Nature 1985;314:592-597
55. Chomyn A, Cleeter MWJ, Ragan CI, Riley M, Dolittle RF, Attardi G. URF6, last unidentified reading frame of human mtDNA, codes for an NADH dehydrogenase subunit. Science 1986;234:614-618
56. Ohnishi T, Ragan CI, Hatefi Y. EPR studies of iron-sulfur clusters in isolated subunits and subtractions of NADH-ubiquinone oxidoreductase. J Biol Chem 1985;260:2782-2788
57. de Coo R, Buddiger P, Smeets H, et al. Molecular cloning and characterization of the active human mitochondrial NADH:ubiquinone oxidoreductase 24-kDa gene (NDUFV2) and its pseudogene. Genomics 1995;26:461-466
58. Hattori N, Suzuki H, Wang Y, et al. Structural organization and chromosomal localization of the human nuclear gene (NDUFV2) for the 24-kDa iron-sulfur subunit of complex I in mitochondrial respiratory chain. Biochem Biophys Res Commun 1995;216:771-777
59. Hattori N, Yoshino H, Tanaka M, Suzuki H, Mizuno Y. Allele in the 24-kDa subunit gene (NDUFV2) ot mitochondrial complex I and susceptibility to Parkinson's disease. Genomics 1998;49:52-58
60. von Heijne G, Steppuhn J, Herrmann RG. Domain structure of mitochondrial and chloroplast targeting peptides. Eur J Biochem 1989;180:535-545
61. Sjoling S, Eriksson AC, Glaser E. A helical element in the C-terminal domain of the N. plumbaginifolia F1 beta presequence is important for recognition by the mitochondrial processing peptidase. J Biol Chem 1994;269:32059-32062
62. Mizuno Y, Saitoh T, Sone N. Inhibition of mitochondrial alpha-ketoglutarate dehydrogenase by 1-methyl-4-phenyl-pyridinium ion. Biochem Biophys Res Commun 1987;143: 971-976
63. Lai JCK, Cooper AJL. Brain α-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J Neurochem 1986;47:1376-1386
64. Nakano K, Takase C, Sakamoto T, et al. Isolation, characterization and structural organization of the gene and pseudogene for the dihydrolipoamide succinyltransferase component of the human 2-oxoglutarate dehydrogenase complex. Eur J Biochem 1994;224:179-189
65. Nakano K, Takase C, Sakamoto T, et al. An unspliced cDNA for human dihydrolipoamide succinyltransferase: characterization and mapping of the gene to chromosome 14q24.2-q24.3. Biochem Biophys Res Commun 1993;196:527-533
66. Nakano K, Matuda S, Sakamoto T, et al. Human dihydrolipoamide succinyltransferase: cDNA cloning and localization on chromosome 14q24.2-q24.3. Biochim Biophys Acta 1993; 1216:360-368
67. Kobayashi T, Matsumine H, Matsubayashi S, Matuda S, Mizuno Y. Polymorphism of the gene encoding dihydrolipoamide succinyltransferase, a subunit of α-ketoglutarate dehydrogenase complex, is associated with the susceptibility to Parkinson disease: a population based study. Ann Neurol 1998;43:120-123
68. Saggu H, Cooksey J, Dexter D, et al. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 1989;53:692-697
69. Borgstahl GEO, Parge HE, Hickey MJ, Beyer WF Jr, Halliwell RA, Tainer JA. The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles. Cell 1992;71:107-118
70. Beck Y, Oren G, Amit B, Levanon A, Gorecki, Hartman JR. Human Mn superoxide dismutase cDNA sequence. Nucleic Acids Res 1987;15:9076
71. Heckl K. Isolation of cDNAs encoding human manganese superoxide dismutase. Nucleic Acids Res 1988;16:6224
72. Ho YS, Crapo JD. Isolation and characterization of complementary DNAs encoding human manganese-containing superoxide dismutase. FEB Lett 1988;229:256-260
73. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human Mn SOD gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 1996;226:561-565
74. Chou PY, Fasman GD. Prediction of protein conformation. Biochemistry 1974;13:222-245
75. Roise D, Horvath SJ, Tomich JM, Richards J, Schatz G. A chemically synthesized presequence of an imported mitochondrial protein can form an amphiphilic helix and perturb natural and artificial phospholipid bilayers. EMBO J 1986;5: 1327-1334
76. Matsumine H, Saito M, Shimoda-Matsubayashi S, et al. Localization of a gene for autosomal recessive form of juvenile parkinsonism (AR-JP) to chromosome 6q25.2-27. Am J Hum Genet 1997;60:588-596
77. Yamamura Y, Sobue I, Ando K, Iida M, Yanagi T, Kono C. Paralysis agitans of early onset with marked diurnal fluctuation of symptoms. Neurology 1973;23:239-244
78. Ishikawa A, Tsuji S. Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. Neurology 1996;47:160-169
79. Takahashi H, Ohama E, Suzuki S, et al. Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology 1994;44:437-441
80. Church SL, Grant JW, Meese EU, Trent JM. Sublocalization of the gene encoding manganese superoxide dismutase (Mn SOD/sod 2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping. Genomics 1992;14:823-825
81. Shimoda-Matsubayashi S, Hattori T, Matsumine H, et al. Mn SOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control. Neurology 1997;49:1257-1262
82. Naoi M, Maruyama W, Dostert P, Kohda K, Kaiya T. A novel enzyme enantio-selectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)-salsolinol. Neurosci Lett 1996;212:183-186
83. Suzuki K, Mizuno Y, Yoshida M. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity and ATP synthesis by tetrahydroisoquinoline. Neurosci Lett 1988;86:105-108
84. McNaught KSP, Thull U, Carrupt PA, et al. Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Biochem Pharmacol 1995;50:1903-1911
85. McNaught KSP, Thull U, Carrupt PA, et al. Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration. Biochem Pharmacol 1996;51:1503-1511
86. Morikawa N, Nakagawa-Hattori Y, Mizuno Y. Effect of dopamine, dimethoxyphenylethylamine, papaverine, and related compounds on mitochondrial respiration and complex I activity. J Neurochem 1996;66:1174-1181
87. Morikawa N, Naio M, Maruyama W, et al. Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexes. J Neural Trans 1998 [in press].
88. Albores R, Heafsey EJ, Drucker G, Fields JZ, Collins MA. Mitochondrial respiratory inhibition by N-methylated betacarboline derivatives structurally resembling N-methyl-4-phenylpyridine. Proc Natl Acad Sci USA 1990;87:9368-9372
89. Makino Y, Ohta S, Tachikawa O, Hirobe M. Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease. Life Sci 1988;43:373-378
90. Niwa T, Takeda N, Tatematsu A, Matsuura S, Yoshida M, Nagatsu T. Migration of tetrahydroisoquinoline, a possible parkinsonian neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry. J Chrornatogt 1988;452:85-91
91. Naoi M, Matsuura S, Takahashi T, Nagatsu T. A N-methyltransferase in human brain catalyzes N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin N-methylisoquinolinium ion. Biochem Biophys Res Commun 1989;161:1213-1219
92. Naoi M, Maruyama W, Dostert P, et al. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies. Brain Res 1996;709:285-295
93. Maruyama W, Sobue G, Matsubara K, Hashizume Y, Dostert P, Naoi M. A dopaminergic neurotoxin, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R) salsolinol, and its oxidation product, 1,2 (N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigrostriatal system of the human brain. Neurosci Lett 1997;223:61-64
94. Maruyama W, Abe T, Tohgi H, Dostert P, Naoi M. A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in Parkinsonian cerebrospinal fluid. Ann Neurol 1996;40:119-122
95. + analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease. Neurology 1995; 45:2240-2245
96. Kuhn W, Muller T, Grosse H, Dierks T, Rommelspacher H. Elevated levels of harman and norharman in cerebrospinal fluid of Parkinsonian patients. J Neurol Sci 1996;103:1435-1440
97. Dexter DT, Carter CJ, Wells FR, et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1989;52:381-389
98. Jenner P, Dexter DT, Sian J, Schapira AHV, Marsden CG. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann Neurol 1992; 32:S82-S87
99. Youdim MBH, Ben-Shachar, Riederer P. Review: the possible role of iron in the etiopathogenesis of Parkinson's disease. Mov Disord 1993;8:1-12
100. Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y. Immunohistochemical detection of 4-hydroxy-nonenal protein adducts in Parkinson's disease. Proc Natl Acad Sci USA 1996;93:2696-2701
101. Uchida K, Stadtman ER. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc Natl Acad Sci USA 1992;89:4544-4548
102. Zhang Y, Marcillat O, Giulvi C, Ernster L, Davis KJA. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem 1990;165:16330-16336
103. Mochizuki H, Imai H, Endo K, et al. Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys. Neurosci Lett 1994;168:251-253
104. Marttila RJ, Lorentz H, Rinne UK. Oxygen toxicity protecting enzymes in Parkinson's disease: increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J Neurol Sci 1988;86:321-331
105. Yoritaka A, Hattori N, Mori H, Kato K, Mizuno Y. An immunohistochemical study on manganese superoxide dismutase in Parkinson's disease. J Neurol Sci 1997;148:181-186
106. Sian J, Dexter DT, Lees AJ, et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 1994;36: 348-355
107. Seaton TA, Jenner P, Marsden CD. Mitochondrial respiratory enzyme function and superoxide dismutase activity following brain glutathione depletion in the rat. Biochem Pharmacol 1996;52:1657-1663